Skip to main content

Table 3 Binary logistic regression model: Which patients opt for genetic testing?

From: Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study

Parameters

B (SE)

Wald

OR

95% CI

p

Age

−.035 (.020)

3.077

.966

.929–1.004

.079

Sex

 male

Ref.

    

 female

.658

2.175

1.931

.805–4.628

.140

Graduation

 Intermediate school or less (< 12 years)

Ref.

    

 High School or higher

.123 (.443)

.076

1.13

.474–2.695

.782

Resilience

.034 (.031)

1.186

1.034

.973–1.099

.276

Social Support

−.897 (.406)

4.889

.408

.184–.903

.027*

Fear of progression (Total)

.413 (.476)

.754

1.512

.595–3.841

.385

General Distress

.301 (.120)

6.272

1.351

1.068–1.710

.012*

Depression

.021 (.081)

.065

1.021

.871–1.196

.799

Anxiety

−.070 (.094)

.567

.932

.776–1-1.119

.451

Quality of Life: Physical

.044 (.028)

2.516

1.045

.990–1-103

.113

Quality of Life: Mental

.044 (.027)

2.679

1.045

.991–1.100

.102

Perceived Risk

.107 (.101)

1.106

1.112

.912–1.357

.293

Treatment

 

20.585

  

<.001**

 Brachytherapy

Reference

    

 Enucleation

2.419 (.548)

19.513

11.233

3.841–32.853

<.001**

 Proton therapy

.892 (.713)

1.565

2.441

.603–9.874

.211

 Endoresection with adjuvant brachytherapy

1.249 (.876)

2.033

3.488

.626–19.421

.154

  1. Note: R2 = .286 (Cox&Snell), .393 (Nagelkerke), −2Log-Likelihood = 157.962, Model χ2(15) = 55.133, **p < .001, * p < .05; Ref. = Reference, OR = Odds Ratio, CI = confidence interval
Back to article page

BMC Psychology

ISSN: 2050-7283

Contact us